Latest news
FDA panel to review Grail's blood-based cancer test - FirstWord PHARMAFirstWord PHARMA · Fri, 07 Aug 2026 21:32:11 GMTGRAIL to face FDA AdCom for Galleri cancer test (GRAL:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 15:43:36 GMTGRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test - PR NewswirePR Newswire · Fri, 07 Aug 2026 15:05:00 GMTCapricor’s Duchenne AdCom Didn’t Fail on Science. It Failed on Statistics. - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 04 Aug 2026 07:38:27 GMTFDA Action Update, July 2026: Approval, Acceptances, and Advisory Committee Vote - NeurologyLiveNeurologyLive · Mon, 03 Aug 2026 15:05:04 GMTFDA Advisory Committee Backs RP1 for Advanced Melanoma - Cure TodayCure Today · Sun, 02 Aug 2026 14:37:01 GMTReplimune stock upgraded at Cantor on FDA vote (REPL:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 15:33:40 GMTTwice-Rejected Advanced Melanoma Treatment Wins FDA Committee Vote - Oncology News CentralOncology News Central · Fri, 31 Jul 2026 07:00:00 GMT